| Literature DB >> 24106642 |
Abstract
Exposure to manganese (Mn) is associated with neurobehavioral effects. There is disagreement on whether commonly occurring exposures in welding, ferroalloy, and other industrial processes produce neurologically significant neurobehavioral changes representing parkinsonism. A review of methodological issues in the human epidemiological literature on Mn identified: (1) studies focused on idiopathic Parkinson disease without considering manganism, a parkinsonian syndrome; (2) studies with healthy worker effect bias; (3) studies with problematic statistical modeling; and (4) studies arising from case series derived from litigation. Investigations with adequate study design and exposure assessment revealed consistent neurobehavioral effects and attributable subclinical and clinical signs and symptoms of impairment. Twenty-eight studies show an exposure-response relationship between Mn and neurobehavioral effects, including 11 with continuous exposure metrics and six with three or four levels of contrasted exposure. The effects of sustained low-concentration exposures to Mn are consistent with the manifestations of early manganism, i.e., consistent with parkinsonism. This is compelling evidence that Mn is a neurotoxic chemical and there is good evidence that Mn exposures far below the current US standard of 5.0 mg/m(3) are causing impairment.Entities:
Keywords: manganism; neurobehavioral signs and symptoms; neuropsychological tests; welding
Year: 2013 PMID: 24106642 PMCID: PMC3791085 DOI: 10.1016/j.shaw.2013.07.003
Source DB: PubMed Journal: Saf Health Work ISSN: 2093-7911
Manganese study populations with neurobehavioral effects: Mean airborne exposure concentrations (in chronological order)
| Study | Work | Total Mn, mg/m3 | |||
|---|---|---|---|---|---|
| am | gm (med) | Range/SD | |||
| Roels et al 1987 | MnO/salts pdn | 141 | 1.33 | 0.94 | 0.07–8.61 |
| Wang et al 1989 | Ferroalloy | 68 | – | – | 0.10 |
| 24 | 0.50–1.50 | ||||
| 8 | 28.8 | ||||
| Iregren 1990 | Foundry | 30 | 0.25 | (0.14) | 0.02–1.40 |
| Sjogren et al 1990 | Welding | – | – | – | – |
| Roels et al 1992 | MnO/battery | 92 | 1.78 | 0.95 | 0.05–10.8 |
| Chia et al 1993 | Ore crushing | – | 0.70 | – | – |
| Mergler et al 1994 | Ferro/silico Mn | 115 | 1.19 | 0.23 | 1.05 |
| Kim et al 1994 | Ferroalloy | 90 | – | 0.60 | 2.3 |
| Chia et al 1995 | Ore crushing | 1.59 | – | – | |
| Lucchini et al 1995 | Ferroalloy | ||||
Med | 19 | – | 0.12 | 0.07–0.62 | |
High | 20 | 0.27 | 0.12–0.65 | ||
| Sjogren et al 1996 | Welding | 68 | – | – | – |
| Lucchini et al 1997 | Ferroalloy | 35 | – | (0.44) | 0.26–0.75 |
| Lucchini et al 1999 | Ferroalloy | 61 | 0.18 | 0.05 | 0.01–1.49 |
| Gibbs et al 1999 | Electrolytic Mn | 75 | 0.18 | 0.11 | – |
| Jin et al 1999 | Welding | 2.10 | – | 0.005-9.3 | |
| Kim et al 1999 | Welding | 23 | – | – | 0.01–0.10 |
| 76 | >0.10 | ||||
| Moon et al 1999 | Welding | 60 | 0.17 | 0.15 | 1.7 |
| Deschamps et al 2001 | Pigments | 139 | 2.05 | – | 0.50–10.2 |
| Sinczuk-Walczal et al 2001 | Battery welding | 75 | 0.39 | 0.15 | 0.54 |
| Myers et al 2003 | Ferroalloy | 509 | 0.82 | – | 1.04 |
| Beuter et al 2004 | Ferroalloy | 10 | – | – | – |
| Kim et al 2005 | Welding (auto, steel, ship) smelter welding rod mfr | 111 | – | 0.50 | 3.7 |
| Yuan et al 2006 | Welding (machine manufacturing) | 68 | 0.14 | – | 0.04–0.20 |
| Wang et al 2006 | Welding | 82 | 0.25 | – | 0.10–0.50 |
| Bowler et al 2007 | Welding (bridge) | 48 | 0.19 | 0.14 | 2.3 |
| Ellingsen et al 2008 | Welding | 96 | – | 0.12 | 0.007–2.3 |
am, arithmetic mean; gm, geometric mean; med, median; SD, standard deviation.
Exposures of 30 min. per day during electrode maintenance.
Inhalable dust.
75th percentile.
Geometric SD.
Summary of investigations observing statistically significant associations between Mn exposure status and motor, cognitive, or symptom outcomes (in order of type of exposure response and year of publication)
| Study/work | n | P | I | M | C | D | R | Hand-eye coordination, motor/postural | Cognitive, mood, autonomic/other | Symptom | Exposure response |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Roels et al, 1987 | 141 | Ch | 1 | 1 | 0 | 0 | 1 | Eye-hand coordinationHand steadinessSimple ReactionTimeTremor (fingers)Rigidity (neck, trunk) | FatigueIrritability | CONT; CAT[2] | |
| Roels et al, 1992 | 92 | Mf | 1 | 1 | 0 | 0 | 1 | Eye-hand coordinationHand steadinessVisual ReactionTimeTremors | CONT; CAT[4] | ||
| Lucchini et al, 1995 | 1920 | Fe | 1 | 1 | 1 | 1 | 1 | Finger Tapping | AdditionSymbol DigitDigit Span | CONT; CAT[3] | |
| Lucchini et al, 1997 | 35 | Fe | 1 | 1 | 1 | 0 | 1 | Aiming Pursuit II | CONT; CAT[2] (increased olfactory acuity with inc. Mn(U)) | ||
| Sinczuk-Walczal et al, 2001 | 75 | Wl | 1 | 0 | 0 | 0 | 1 | IrritabilityParesthesiaSleepiness | CONT; CAT[2] | ||
| Myers et al, 2003 | 509 | Fe | 1 | 1 | 1 | 1 | 1 | Santa AnaDexterity | Digit SymbolDigit SpanBenton VisualRetention | CONT; CAT[3] | |
| Kim et al, 2005 | 111 | WlMf | 1 | 1 | 1 | 0 | 1 | Factor: psychomotor | Factor: affect, factor: attention-memory | CONT (structural equation model) | |
| Wang et al, 2006 | Wl | 1 | 1 | 1 | 1 | 1 | Simple ReactionTime | Digit Span total, forward, backward | Anger-hostilityFatigue-inertia HeadacheDizzinessConcentrationWeakness | CONT; CAT[2] (Pb confounded) | |
| Park et al, 2006 | 4844 | Wl | – | – | – | – | – | Working MemoryIndexVerbal IQStroop Color-word | CONT (duplicates Bowler, 2007) | ||
| Bowler et al, 2007 | 43 | Wl | 1 | 1 | 1 | 0 | 1 | Tremors | Executive functionVerbal learningWorking memoryConcentration and sequencingImmediate memory | FatigueSleep disturbanceDepressionAnxietyNumbness | CONT; CAT[2] |
| Ellingsen et al, 2008 | Wl | 1 | 1 | 1 | 1 | 1 | Finger Tapping | Digit Symbol | NCTB Q16 | CONT; CAT[2] | |
| Wastensson et al, 2011 | 17 | Wl | 1 | 1 | 0 | 0 | 1 | Pegboard | CONT; CAT[2] | ||
| Wang et al, 1989 | 68248 | Fe | 1 | 1 | 1 | 0 | 0 | BradykinesiaRigidityGait abnormalityWeakness | Dislike of talking | FatigueLoss of libido | CAT[4] |
| Sjogren et al, 1990 | – | Wl | 1 | 0 | 1 | 0 | 0 | NCTB Q16: nervous system symptoms | CAT[4] | ||
| Mergler et al, 1994 | 38 | Fe | 1 | 1 | 1 | 0 | 0 | Luria Total ScoreFinger TappingGraphomotor NineHole Steadiness | Profuse sweating Memory loss | AgitationAnxietyFatigueNightmarePOMS | CAT[2] (matched)CAT[4] (matched) |
| Jin et al, 1999 | na | Wl | 1 | 1 | 1 | 0 | 0 | Pursuit AimingFinger Tapping Santa AnaDexterity | Inability to concentrate | Muscle symptomsNeurological symptoms | CAT[4] |
| Lucchini et al, 1999 | 61 | Fe | 1 | 1 | 1 | 1 | 0 | Finger Tapping disequilibria tremors | AdditionDigit SymbolDigit Span | Irritability | CAT[4] |
| Kim et al, 1999 | 2376 | Wl | 1 | 1 | 1 | 1 | 0 | Pursuit AimingFinger Tapping, Santa AnaDexterity | Digit SymbolDigit Span | CAT[3] | |
| Park et al, 2006 | Wl | – | – | – | – | – | Parkinson disease, parkinsonism | CAT[3] (vicarious finding | |||
| Iregren, 1990 | 30 | Fe | 1 | 1 | 1 | 1 | 0 | Finger TappingSimple ReactionTime | Digit Span | CAT[2] | |
| Chia et al, 1993 | – | Or | 1 | 1 | 1 | 1 | 0 | Pursuit Aiming | Benton VisualRetentionDigit Symbol | 20 of 37 adverse symptoms insomnia | CAT[2] (motor speed, visual scanning, visuomotor performances) |
| Kim et al, 1994 | 1454990 | Fe | 1 | 1 | 0 | 0 | 0 | Difficulty writing | Reduced libido | CAT[2,2] | |
| Chia et al, 1995 | – | Or | 1 | 1 | 0 | 0 | 0 | Postural sway (eyes closed) | CAT[2] (two postural stability parameters) | ||
| Sjogren et al, 1996 | 68 | Wl | 1 | 1 | 1 | 0 | 0 | Finger TappingPegboardLuria Nebraska (items 2, 22) | NCTB Q16: inability to concentrate memory loss | NCTB Q16: depression | CAT[2] |
| Moon et al, 1999 | 60 | Wl | 1 | 1 | 1 | 0 | 0 | TremorsGait disturbance | AmnesiaGeneral weaknessSpeech disturbance | CAT[2] | |
| Gibbs et al, 1999 | 75 | Ch | 0 | 0 | 0 | 0 | 0 | Reaction timeGait disturbance | Memory loss | Sleep disturbance | CAT[2]; CONT (no effects on individual measures but 5/7 show nonsignificant deficits) |
| Deschamps et al, 2001 | 30 | Ch | 1 | 0 | 0 | 0 | 0 | Asthenia | HeadacheSleep disturbance | CAT[2] | |
| Beuter et al, 2004 | 10 | Fe | 1 | 1 | 0 | 0 | 0 | Postural tremor | CAT[2] (tremor parameters) | ||
| Yuan et al, 2006 | 68 | WlMf | 1 | 1 | 1 | 1 | 0 | Pursuit Aiming reaction time (improved) | Digit SpanDigit Symbol | Depression-dejectionTension-anxietyVigor-activityFatigue-inertia | CAT[2] |
| Marsh et al, 2006 | Wl | – | – | – | – | – | Parkinson's disease, parkinsonism | CAT[2] (vicarious finding | |||
| Chang et al, 2009 | 43 | Wl | 1 | 1 | 1 | 1 | 0 | Finger TappingPegboard tremorsHand coordination | Digit SymbolDigit SpanStroopComplex figure | CAT[2] ; CONT (on pallidal index) | |
| Sanchez-Ramos et al, 2011 | 37 | Wl | 1 | 1 | 0 | 0 | 0 | Tremors | CAT[2] | ||
| TOTALS | 28 | 25 | 19 | 10 | 11 | ||||||
C, cognitive outcomes (1 = yes, 0 = no); Ch, chemical; D, Digit Symbol/Digit Span deficits (1 = yes, 0 = no); Exposure response, a reasonably well-designed comparison, using either continuous (CONT) or categorical [CAT (levels)] models of exposure response; Fe, ferroalloy; I, Include as positive study (1 = yes, 0 = no); M, motor outcomes (1 = yes, 0 = no); Mf, manufacturing; n, size of study group; NCTB, Neurobehavioral Core Test Battery, developed by WHO, with symptom questionnaire (Q16); Or, ore processing; P, Process; POMS, Profile of Mood States; R, continuous exposure metric showing exposure response (X-R) (1 = yes, 0 = no); Wl, welding.
Proposed interpretation of published data regarding parkinsonism other than Parkinson's disease.
Comparison of adverse neurobehavioral effect magnitudes for neurotoxic metals: fractional score change∗
| Study | Finger tapping | Symbol digit | Digit symbol | Digit span | Peg board | Trail-B | Hand steadiness | Santa ana | Wisconsin total error |
|---|---|---|---|---|---|---|---|---|---|
| Mercury (per mg/m3-yr of cumulative exposure) | |||||||||
| Ngim et al, 1992 | 0.291 | 0.582 | – | 0.885 | 0.185 | 1.277 | – | – | – |
| Liang et al, 1993 | 0.146 | 0.431 | – | – | – | – | – | – | – |
| Piikivi et al, 1989 | 0.096 | 0.188 | – | 0.127 | – | – | – | – | – |
| Lead (per measures based on bone/blood lead) | |||||||||
| Stewart et al, 1999 | 0.029 | 0.024 | – | 0.052 | 0.017 | – | – | – | – |
| Chia et al, 1997 | – | – | 0.244 | – | 0.159 | 0.496 | – | 0.089 | – |
| Barth et al, 2002 | – | – | 0.025 | – | – | – | – | 0.307 | |
| Lindgren et al, 1996 | 0.018 | 0.022 | 0.036 | 0.016 | 0.065 | – | – | – | |
| Manganese (per mg/m3-y of cumulative exposure) | |||||||||
| Lucchini et al, 1995 | 0.095 | 0.374 | – | 0.227 | – | – | – | – | – |
| Ellingsen et al, 2008 | 0.016 | – | 0.026 | 0.036 | 0.004 | – | 0.125 | – | – |
| Wastensson et al, 2012 | 0.0005 | – | – | – | 0.023 | – | – | – | – |
| Mergler et al, 1994 and Baldwin et al, 2008 | 0.011 | 0.004 | – | 0.010 | – | 0.036 | 0.089 | – | – |
| Lucchini et al, 1999 | 0.017 | 0.039 | – | 0.028 | – | – | – | – | – |
| Lucchini et al, 1999 | 0.058 | 0.144 | – | 0.183 | – | – | – | – | – |
| Kim et al, 1999 | 0.072 | – | 0.225 | 0.151 | – | – | – | 0.042 | – |
| Kim et al, 1999 | 0.438 | – | 1.206 | 0.369 | – | – | – | – | – |
| Iregren, 1990 | 0.029 | – | – | 0.035 | – | – | – | – | – |
| Yuan et al, 2006 | – | – | 0.079 | 0.053 | – | – | – | – | – |
| Chang et al, 2009 | 0.034 | – | 0.040 | 0.084 | 0.040 | – | – | – | – |
Calculated as: (1) for discrete analyses, difference in score between exposed and unexposed group divided by control group score and by average cumulative exposure, or (2) for regression-based results, estimated effect at 1 mg/m3-year divided by intercept or nominal baseline normal score.
Using normal baseline levels and based on average observed community tibial bone lead levels.
Based on change per 250 μg/dL–year of cumulative lead blood level.
Based on change per 250 μg/dL–year of cumulative lead blood level comparing two groups: 268 versus 1227 μg/dL–year Pb (mean lead = 26.1 vs. 52.8 μg/dL, respectively).